Trial intelligence / Profile preview

Low-dose Adrenaline for Bleeding in Total Hip Arthroplasty

NCT01708642Phase 3Completed

Sponsor
Rigshospitalet
Start
Nov 2012
Primary completion
Sep 2013
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of epinephrine in Intraoperative blood loss (EBL), sponsored by Rigshospitalet. Started Nov 2012; status: completed.

02

Drugs

epinephrine
03

Conditions

Intraoperative blood loss (EBL)

Beyond the preview

Go deeper on NCT01708642.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01708642.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call